Nizatidine: Clinical Trials

11 trials of Nizatidine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 1 unknown. 5 Phase 1, 2 Phase 4, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Unknown 1
Phase 42Completed 2
Not applicable1Completed 1
Phase 31Completed 1

Follow Nizatidine: new trials by email Literature Review of Nizatidine trials Research Report on Nizatidine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis
Mucotra SR Tablet 150mg, Axid Capsule 150mg - Gastritis
Phase 4CompletedDaewoong Pharmaceutical Co. LTD.2602021-09-302024-07-01
Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19
No intervention (Retrospective Cohort Observational) - COVID-19
CompletedSeoul National University Hospital4000002021-05-012024-11-29
[KJ-INT-002] BE Study
INT-2150, Irsogladine maleate 2 mg+Nizatidine 150 mg - Gastritis
Phase 1UnknownKukje Pharma372017-11-022018-04-26
Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects
Nizatidine, Lisinopril, Placebo - Gastroparesis
Phase 1CompletedAdil Bharucha242014-07-012015-04-30
Improvement of Tinnitus After Oral Zinc on Patients With Noise-induced Hearing Loss
zinc gluconate - Hearing Loss, Noise-Induced, Tinnitus, Noise Induced
Not applicableCompletedChang Gung Memorial Hospital202013-12-012016-11-01
Proton Pump Inhibitors and Risk of Community-acquired Pneumonia
esomeprazole, omeprazole, pantoprazole - Gastroesophageal Reflux Disease (GERD), Community-acquired Pneumonia
CompletedCanadian Network for Observational Drug Effect Studies, CNODES42385042011-09-012015-09-22
Drug-Drug Interaction Study With Metformin and Nizatidine
Metformin and nizatidine, Metformin - Healthy
Phase 1CompletedUniversity of California, San Francisco102011-09-012014-04-10
Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD)
nizatidine (axid), placebo - Gastroesophageal Reflux Disease, GERD
Phase 3CompletedBraintree Laboratories1382006-08-012009-11-18
Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions
Nizatidine, Axid - Healthy
Phase 1CompletedDr. Reddy's Laboratories Limited262004-07-012010-07-14
Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Non- Fasting Conditions
Nizatidine, Axid - Healthy
Phase 1CompletedDr. Reddy's Laboratories Limited262004-07-012010-07-14
Weight Gain Management in Patients With Schizophrenia
Olanzapine Hydrochloride, Nizatidine, Placebo - Schizophrenia
Phase 4CompletedEli Lilly and Company742003-02-012007-06-13

Conditions studied

Gastritis (2)  ·  Gastroesophageal Reflux (2)  ·  COVID-19 (1)  ·  Community-Acquired Pneumonia (1)  ·  Gastroparesis (1)  ·  Hearing Loss, Noise-Induced (1)  ·  Heartburn (1)  ·  Pneumonia (1)  ·  Schizophrenia (1)  ·  Tinnitus (1)

Sponsors

Dr. Reddy's Laboratories Limited (2)  ·  Adil Bharucha (1)  ·  Braintree Laboratories (1)  ·  Canadian Network for Observational Drug Effect Studies, CNODES (1)  ·  Chang Gung Memorial Hospital (1)  ·  Daewoong Pharmaceutical Co. LTD. (1)  ·  Eli Lilly and Company (1)  ·  Kukje Pharma (1)  ·  Seoul National University Hospital (1)  ·  University of California, San Francisco (1)

Countries

South Korea (3)  ·  United States (3)  ·  Brazil (1)  ·  Canada (1)

Top investigators

Charu Gautam, M.D (2)  ·  Adil Bharucha, MBBS, MD (1)  ·  John McGowan (1)  ·  Kathleen M Giacomini, Ph.D (1)  ·  Kristian Filion, PhD (1)  ·  Myung Kyu Choi (1)  ·  Sang-Heon Cho (1)

Results publications

PMID 23856153

NIH funding

P01DK068055 (1), R01GM036780 (1), UL1RR024150 (1)